FDA Approves "Investigational New Drug" Application for Cannabis In Migraine Treatment

Press release on FDA approval for Ethan Russo, MD, a neurologist in Missoula, Montana, to study the effects of smoked cannabis (marijuana) as compared to oral dronabinol (Marinol®) and injected sumatriptan (Imitrex®- the current "gold standard") in the acute treatment of migraine.